istituto di ricerca

Fondazione Epatocentro Ticino

Biomedicina
 
1) programma di ricerca

Hepatitis C Virus HCV - A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection (D3FEAT)

2) programma di ricerca

Statoepatite non alcolica NASH - Phase 2b Study in NASH to Assess IVA337 (NATIVE)

3) programma di ricerca

Emocromatosi ereditaria - A Two-year Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis

4) programma di ricerca

Statoepatite non alcolica NASH - Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis (TANDEM)

5) programma di ricerca

Statoepatite non alcolica NASH - Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH

6) programma di ricerca

Epatite autoimmune - ADCC Mediated B-Cell dEpletion and BAFF-R Blockade (AMBER)

7) programma di ricerca

Hepatitis C Virus HCV - Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection (REACT)

8) programma di ricerca

Non-alcoholic Statohepatitis NASH - Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

9) programma di ricerca

Statoepatite non alcolica NASH - Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis (STELLAR 3)

10) programma di ricerca

Statoepatite non alcolica NASH - Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (STELLAR 4)

11) programma di ricerca

Trapianto - Reducing the Burden of Influenza after Solid-Organ Transplantation: the STOP-FLU trial [Swiss Trial in solid Organ transplantation on Prevention of inFLUenza]